Item 16. FORM 10-K SUMMARY

Not applicable.

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.


Keurig Dr Pepper Inc.
By:	/s/ Ozan Dokmecioglu

Name:		Ozan Dokmecioglu
Title:		Chief Financial Officer of Keurig Dr Pepper Inc.
		(Principal Financial Officer)
Date:		February 24, 2022

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.


By:	/s/ Robert J. Gamgort		By:	/s/ Ozan Dokmecioglu
	Name:	Robert J. Gamgort		Name:	Ozan Dokmecioglu
	Title:	Chief Executive Officer, President and Executive Chairman of the Board of Directors		Title:	Chief Financial Officer
		Keurig Dr Pepper Inc.			Keurig Dr Pepper Inc.
	Date:	February 24, 2022		Date:	February 24, 2022

By:	/s/ Angela A. Stephens		By:	/s/ Olivier Goudet
	Name:	Angela A. Stephens		Name:	Olivier Goudet
	Title:	Senior Vice President and Controller		Title:	Director
		(Principal Accounting Officer)
	Date:	February 24, 2022		Date:	February 24, 2022

By:	/s/ Peter Harf		By:	/s/ Juliette Hickman
	Name:	Peter Harf		Name:	Juliette Hickman
	Title:	Director		Title:	Director
	Date:	February 24, 2022		Date:	February 24, 2022

By:	/s/ Paul S. Michaels		By:	/s/ Pamela Patsley
	Name:	Paul S. Michaels		Name:	Pamela Patsley
	Title:	Director		Title:	Director
	Date:	February 24, 2022		Date:	February 24, 2022

By:	/s/ Lubomira Rochet		By:	/s/ Debra Sandler
	Name:	Lubomira Rochet		Name:	Debra Sandler
	Title:	Director		Title:	Director
	Date:	February 24, 2022		Date:	February 24, 2022

By:	/s/ Robert Singer		By:	/s/ Justine Tan
	Name:	Robert Singer		Name:	Justine Tan
	Title:	Director		Title:	Director
	Date:	February 24, 2022		Date:	February 24, 2022

By:	/s/ Nelson Urdaneta		By:	/s/ Larry Young
	Name:	Nelson Urdaneta		Name:	Larry Young
	Title:	Director		Title:	Director
	Date:	February 24, 2022		Date:	February 24, 2022

Previous: Item 15. EXHIBITS, FINANCIAL STATEMENT SCHEDULES